SCHEMBL12969822

SCHEMBL12969822

Cc1cc(N2CCCC(O)C2)nc2sc3c(N)ncnc3c12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 5/20 0.61
▸ CDC7 O00311 6/20 0.54
▸ DBF4 Q9UBU7 6/20 0.54
▸ CHUK O15111 2/20 0.54
▸ PLK4 O00444 1/20 0.54
▸ AURKA O14965 1/20 0.54
▸ ROCK2 O75116 1/20 0.54
▸ FYN P06241 1/20 0.54
▸ PIM1 P11309 1/20 0.54
▸ PRKACA P17612 1/20 0.54
▸ RPS6KB1 P23443 1/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ MARK3 P27448 1/20 0.54
▸ AKT1 P31749 1/20 0.54
▸ FLT4 P35916 1/20 0.54
▸ KDR P35968 1/20 0.54
▸ CSNK1D P48730 1/20 0.54
▸ GSK3A P49840 1/20 0.54
▸ LIMK1 P53667 1/20 0.54
▸ PRKCD Q05655 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12969830 0.88 CDC7 (0.58) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL12969828 0.83 CDC7 (0.48) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL12969908 0.80 KDM4E (0.63) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL12817782 0.79 MAPK1 (0.64) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL12969835 0.77 SMN1; SMN2 (0.67) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL12969827 0.77 CDC7 (0.52) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL4892342 0.73 IKBKB (0.61) IKBKBCHUK
SCHEMBL12969907 0.73 CDC7 (0.53) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL4903009 0.71 CDC7 (1.00) IKBKBCDC7DBF4CHUKPLK4
SCHEMBL4903115 0.68 IKBKB (0.60) IKBKBCDC7DBF4CHUKPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012131297-A1 PYRIDO [3',2' :4,5] THIENO [3, 2-D] PYRIMIDIN- 4 - YLAMINE DERIVATIVES AND THEIR THERAPEUTICAL USE BAELL JONATHAN BAYLDON (AU) 2012-10-04 — — WO disclosed
Send feedback